UT-MD Anderson Cancer Center: Study Opens New Avenue for Immunotherapy Drug Development
April 20, 2024
April 20, 2024
HOUSTON, Texas, April 20 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on April 19, 2024:
* * *
Method utilizes engineered peptides to build up the body's natural response
* * *
In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides . . .
* * *
Method utilizes engineered peptides to build up the body's natural response
* * *
In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides . . .